Factor VIII - PDFSEARCH.IO - Document Search Engine

Factor VIII
Results: 143

#	Item
41	Microsoft Word - PD2013_000 - Policy Statement.DOCX Add to Reading List Source URL: www.cec.health.nsw.gov.au Language: English - Date: 2014-05-15 00:15:10 Blood Von Willebrand disease Royal Prince Alfred Hospital Coagulation Bleeding Factor VIII Westmead Hospital Patient safety Haemophilia B Haemophilia Medicine Health
42	For Information on 9 June 2003 Paper No. CB[removed]) Legislative Council Panel on Health Services Add to Reading List Source URL: www.legco.gov.hk Language: English - Date: 2004-03-15 06:32:56 Biology Blood Factor VIII AIDS HIV Recombinant DNA Department of Health HIV-tainted blood scandal HIV/AIDS in Japan Haemophilia HIV/AIDS Health
43	October[removed]This month n Spotlight Add to Reading List Source URL: www.hkma.org Language: English - Date: 2013-05-09 08:50:58 Medicine Coagulation system Osteopathies Denosumab Osteoporosis Factor VIII Coagulation Rheumatoid arthritis Bisphosphonate Haemophilia Anatomy Health
44	Orthopedic Complications and Treatment Related to Chronic Hemarthrosis Susan Geraghty, RN, MBA CHRONIC JOINT ARTHROPATHY The term “target joint” is used frequently in hemophilia care to describe a joint that has Add to Reading List Source URL: www.hemophilia.org Language: English - Date: 2014-04-22 11:15:55 Haemophilia Rheumatology Arthropathies Hemarthrosis Arthritis Synovial fluid Factor VIII Coagulopathy Synovectomy Medicine Arthrology Health
45	Introduction to von Willebrand Disease Mary Lesh RN, MS, CPNP OVERVIEW Von Willebrand Disease (VWD) is the most common hereditary bleeding disorder in humans, with an estimated prevalence ranging upward to 1% of the gene Add to Reading List Source URL: www.hemophilia.org Language: English - Date: 2014-04-22 10:41:30 Coagulation system Von Willebrand disease Von Willebrand factor Ristocetin Coagulation Desmopressin Platelet Haemophilia Factor VIII Blood Medicine Anatomy
46	Introduction to Bleeding Disorders Dawn Banks RN (Original author Regina B. Butler, RN) Bleeding disorders are relatively rare genetic disorders characterized by increased or prolonged bleeding due to abnormal coagulatio Add to Reading List Source URL: www.hemophilia.org Language: English - Date: 2014-04-18 12:26:40 Haemophilia Blood tests Acute phase proteins Peripheral membrane proteins Coagulation Von Willebrand disease Coagulopathy Factor VIII Factor VII Blood Coagulation system Anatomy
47	Treatment of Hemophilia A and B Marianne McDaniel, RN INTRODUCTION Treatment for patients with hemophilia and other bleeding disorders has evolved over the past several decades. Replacement of the specific missing plasma Add to Reading List Source URL: www.hemophilia.org Language: English - Date: 2014-04-22 11:05:24 Biology Haemophilia Desmopressin Recombinant proteins Coagulation Blood products Von Willebrand disease Factor VIII CSL Behring Blood Anatomy Coagulation system
48	Downloaded from http://pmj.bmj.com/ on March 1, [removed]Published by group.bmj.com Add to Reading List Source URL: pmj.bmj.com Language: English Coagulation system Medicine Factor VIII Desmopressin Factor IX Coagulation Von Willebrand disease Fresh frozen plasma AIDS Haemophilia Blood Biology
49	Measure Number Theme HAE03 Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2014-08-12 08:04:41 Chemistry Peripheral membrane proteins Factor VIII Factor VII Methadone Factor IX Coagulation system Blood Haemophilia
50	List of medicinal products marketed by LFB BIOMEDICAMENTS, in France. (By alphabetical order): ACLOTINE® 100 IU/ml – Human antithrombin ALFALASTIN® 33.33 mg/ml – Human alpha-1 antitrypsin Add to Reading List Source URL: www.lfb.fr Language: English - Date: 2013-02-11 10:35:59 Biology Thrombin Coagulation Antithrombin Von Willebrand disease Factor X Factor VIII CSL Behring CSL Limited Coagulation system Blood Anatomy

UPDATE